Browse Title Index

Issue Title
Vol 17, No 6 (2010) Treatment for glioblastoma multiforme: current guidelines and Canadian practice Abstract   PDF
A. Ghose, G. Lim, S. Husain
Vol 14, No 5 (2007) Treatment of Depression in Cancer Patients Details   PDF
Gary Rodin, Mark Katz, Nancy Lloyd, Esther Green, Rebecca K.S. Wong
Vol 19, No 6 (2012) Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations Abstract   PDF   HTML
S. L'Esperance, F. Vincent, M. Gaudreault, J.A. Ouellet, M. Li, A. Tosikyan, S. Goulet, Comité de l'évolution des pratiques en oncologie
Vol 23, No 3 (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives Abstract   PDF   HTML
J. Spiliotis, E. Halkia, E. de Bree
Vol 21, No 3 (2014) Treatment outcomes for male breast cancer: a single-centre retrospective case–control study Abstract   PDF   HTML
M. Rushton, A. Kwong, H. Visram, N. Graham, W. Petrcich, S. Dent
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line Abstract   PDF   HTML
N.B. Leighl
Vol 22, No 6 (2015) Treatment patterns among Canadian men diagnosed with localized low-risk prostate cancer Abstract   PDF   HTML
C. Sandoval, K. Tran, R. Rahal, G. Porter, S. Fung, C. Louzado, J. Liu, H. Bryant
Vol 23, No 6 (2016) Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective study Abstract   PDF   HTML
S. Kayaniyil, M. Hurry, J. Wilson, P. Wheatley-Price, B. Melosky, J. Rothenstein, V. Cohen, C. Koch, J. Zhang, K. Osenenko, G. Liu
Vol 24, No 4 (2017) Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study Abstract   PDF   HTML
A. Dragomir, J. Rocha, M. Vanhuyse, F.L. Cury, W. Kassouf, J. Hu, A.G. Aprikian
Vol 19, No 5 (2012) Treatment recommendations for the use of bone-targeted agents in 2011— report from the 6th Annual Bone and the Oncologist New Updates meeting Abstract   PDF   HTML
I. Kuchuk, A. Paterson, E. Amir, M. Clemons, N. Bouganim
Vol 26, No 2 (2019) Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot–Marie–Tooth disease Abstract   PDF   HTML
J. D. Bernstock, J. L. Cohen, S. Singh, C. W. Schlappi, J. B. Fiveash, J. M. Johnston, P. Fequiere, B. A. Orr, R. Li, G. K. Friedman
Vol 23, No 3 (2016) Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002–2009: a population-based cohort study Abstract   PDF   HTML
H.H. Thein, Y. Qiao, S.K. Young, W. Zarin, E.M. Yoshida, C. de Oliveira, C.C. Earle
Vol 18, No 4 (2011) Triple-negative and basal-like breast cancer: implications for oncologists Details   PDF   HTML
J. Lachapelle, W.D. Foulkes
Vol 18, No 4 (2011) Triple-negative breast cancers: an updated review on treatment options Abstract   PDF   HTML
K. B. Reddy
Vol 21, No 3 (2014) Truth be told— perspectives on openness Abstract   PDF   HTML
R.E. Hughes, J. Richards
Vol 22, No 1 (2015) Tumour inflammatory response: adding fuel to the fire? Abstract   PDF   HTML   Erratum
M. Valdes, M.R. Chasen
Vol 19, No 5 (2012) Tumour size predicts long-term survival among women with lymph node-positive breast cancer Abstract   PDF   HTML
S.A. Narod
Vol 15, No 5 (2008) Two Cases of Acrometastasis to the Hands and Review of the Literature Abstract   PDF
Candi J. Flynn, Cyril Danjoux, John Wong, Monique Christakis, Joel Rubenstein, Albert Yee, Darwin Yip, Edward Chow
Vol 21, No 6 (2014) Two cases of cutaneous drug eruption associated with temozolomide therapy for glioblastoma Abstract   PDF   HTML
E. Deluche, S. Leobon, F. Touraine, P. Clavère
Vol 21, No 3 (2014) Two indicators of hospital resource efficiency in cancer care Abstract   PDF   HTML
R. Rahal, J. Xu, S. Fung, H. Bryant
Vol 19, No 6 (2012) Ubiquitin pathway and ovarian cancer Abstract   PDF   HTML   CORRIGENDA
Z. Rao, Y. Ding
Vol 17, No 6 (2010) Umbilical metastasis: a case series of four Sister Joseph nodules from four different visceral malignancies Abstract   PDF
M. Palaniappan, W.M. Jose, A. Mehta, K. Kumar, K. Pavithran
Vol 21, No 5 (2014) Uncommon case of brain metastasis in a patient with a history of heavy smoking Abstract   PDF   HTML
M. Scharl, B. Bode, E. Rushing, A. Knuth, T. Rordorf
Vol 19, No 1 (2012) Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis Abstract   PDF   HTML
A. Bagnato, L. Rosanò
Vol 25, No 4 (2018) Understanding the reasons for provincial discordance in cancer drug funding— a survey of policymakers Abstract   PDF   HTML
A. Srikanthan, N. Penner, K.K.W. Chan, M. Sabharwal, A. Grill
Vol 25, No 4 (2018) Unnecessary variation in practice: how to improve cancer care through pragmatic trials Abstract   PDF   HTML
N. LeVasseur, D. Fergusson, M. Clemons
Vol 22, No 4 (2015) Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer Abstract   PDF   HTML
V. Kumar, Y. Xu
Vol 26 (2019): A fresh look at Therapeutic Advances in Soft-tissue Sarcoma Update on Systemic Therapy for Advanced Soft Tissue Sarcoma Abstract   PDF   HTML
A. Smrke, Y. Wang, C. Simmons
Vol 21, No 5 (2014) Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer Abstract   PDF   HTML
M.A. Socinski
Vol 14, No 4 (2007) Updated recommendations from the Canadian National consensus meeting on HER2/neu testing in breast cancer Abstract   PDF
Wedad Hanna, Frances P O’Malley, P Barnes, R Berendt, L Gaboury, A Magliocco, N Pettigrew, S Robertson, S Sengupta, B Têtu, T Thomson
Vol 24, No 1 (2017) Updates from the 2016 American Society of Hematology annual meeting: practice-changing studies in untreated follicular lymphoma Abstract   PDF   HTML
C. Owen, D. MacDonald, A. Aw, A. Christofides
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in relapsed and refractory mantle cell lymphoma Abstract   PDF   HTML
C. Owen, J. Kuruvilla, A. Christofides
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in untreated chronic lymphocytic leukemia Abstract   PDF   HTML
C. Owen, C. Toze, A. Christofides
Vol 26, No 4 (2019) Updates from the 2019 American Society of Clinical Oncology and European Hematology Association annual meetings: a Canadian perspective on high-risk cytogenetics in multiple myeloma Abstract   PDF   HTML
R. LeBlanc, K. Song, D. White, A. Christofides, S. Doucette
Vol 24, No 2 (2017) Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists Abstract   PDF   HTML
M.A. O'Brien, S. Dhesy-Thind, C. Charles, M. Hammond Mobilio, N.B. Leighl, E. Grunfeld
Vol 18, No 3 (2011) Uptake of novel medical therapies in the general population Abstract   PDF   HTML
C. M. Booth, B. Rapoport
Vol 22, No 1 (2015) Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer Abstract   PDF   HTML
F. Santos, A. Dragomir, W. Kassouf, E. Franco, A. Aprikian
Vol 26, No 2 (2019) U.S. prevalence of endocrine therapy–naïve locally advanced or metastatic breast cancer Abstract   PDF   HTML
A. P. Nunes, C. Liang, W. J. Gradishar, T. Dalvi, J. Lewis, N. Jones, E. Green, M. Doherty, J. D. Seeger
Vol 19, No 4 (2012) Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience Abstract   PDF   HTML
X. Zhu, N. Bouganim, L. Vandermeer, S. F. Dent, G. Dranitsaris, M. J. Clemons
Vol 22, No 2 (2015) Use of bevacizumab as a first-line treatment for metastatic breast cancer Abstract   PDF   HTML
L. Manso, F. Moreno, R. Márquez, B. Castelo, A. Arcediano, M. Arroyo, A.I. Ballesteros, I. Calvo, M.J. Echarri, S. Enrech, A. Gómez, R. González del Val, E. López-Miranda, M. Martín-Angulo, N. Martínez-Jañez, C. Olier, P. Zamora
Vol 23 (2016): Use of Cannabinoids in Cancer Care Use of cannabinoids in cancer care: palliative care Abstract   PDF   HTML
S.K. Aggarwal
Vol 21, No 4 (2014) Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years Abstract   PDF   HTML
N. Boame, G. Gresham, D. Jonker, G. Martel, F. Balaa, T. Asmis
Vol 21, No 3 (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline Abstract   PDF   HTML
X. Kostaras, F. Cusano, G.A. Kline, W. Roa, J. Easaw
Vol 21, No 1 (2014) Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy Abstract   PDF   HTML
S.P. Krotneva, A. Ramjaun, K.E. Reidel, T. Eguale, N. Trabulsi, N. Mayo, R. Tamblyn, A.N. Meguerditchian
Vol 23, No 5 (2016) Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data Abstract   PDF   HTML
K. Tran, R. Rahal, M. Brundage, S. Fung, C. Louzado, M. Milosevic, J. Xu, H. Bryant
Vol 21, No 6 (2014) Use of pet in the management of non-small-cell lung cancer in Canada Abstract   PDF   HTML
E. Vorauer, C. Louzado, K. DeCaria, J. Hernandez, R. Rahal, J. Niu, G. Lockwood, H. Bryant
Vol 24, No 2 (2017) Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer Abstract   PDF   HTML
C. Kendell, K.M. Decker, P.A. Groome, M.L. McBride, L. Jiang, M.K. Krzyzanowska, G. Porter, D. Turner, R. Urquhart, M. Winget, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
Vol 21, No 3 (2014) Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer Abstract   PDF   HTML
M. Mathews, D. Ryan, V. Gadag, R. West
Vol 25, No 6 (2018) Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting Abstract   PDF   HTML
S. Nazha, S. Tanguay, A. Kapoor, M. Jewett, C. Kollmansberger, L. Wood, G. Bjarnason, D. Heng, D. Soulières, N. Reaume, N. Basappa, E. Lévesque, A. Dragomir
Vol 22, No 3 (2015) Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review Abstract   PDF   HTML
P.M. Ellis, N. Coakley, R. Feld, S. Kuruvilla, Y.C. Ung
Vol 22, No 1 (2015) Use of the word “cured” for cancer patients—implications for patients and physicians: the Siracusa charter Abstract   PDF   HTML
P. Tralongo, L. Dal Maso, A. Surbone, A. Santoro, U. Tirelli, V. Sacchini, C. Pinto, S. Crispino, F. Ferraù, G. Mandoliti, G. Tonini, A. Russo, D. Santini, A. Madeddu, V. Panebianco, S. Pergolizzi, D. Respini, C. Rolfo, M. Bongiovanni, F. De Lorenzo, C. Spatola, F. Di Raimondo, M. Terenziani, M. Peeters, C. Castoro
Vol 24, No 4 (2017) User survey of Nanny Angel Network, a free childcare service for mothers with cancer Abstract   PDF   HTML
L. Cohen, N. Schwartz, A. Guth, A. Kiss, E. Warner
Vol 22, No 5 (2015) Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma Abstract   PDF   HTML
A. Schiavi, J. Lavigne, R. Turcotte, L. Karsprzak, N. Dumas, G. Chong, C. Freeman, M. Alameldin, P. Galiatsatos, L. Palma, W.D. Foulkes
Vol 18, No 2 (2011) Using a positive self-talk intervention to enhance coping skills in breast cancer survivors: lessons from a community based group delivery model Abstract   PDF   HTML
R. Hamilton, B. Miedema, L. MacIntyre, J. Easley
Vol 24, No 6 (2017) Using family history forms in pediatric oncology to identify patients for genetic assessment Abstract   PDF   HTML
A. Hamilton, E. Smith, J. Hamon, E. Tomiak, M. Bassal, S.L. Sawyer
Vol 21, No 6 (2014) Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review Abstract   PDF   HTML
M. Smoragiewicz, J. Laskin, D. Wilson, K. Ramsden, J. Yee, S. Lam, T. Shaipanich, Y. Zhai, C. Ho
Vol 22, No 3 (2015) Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience Abstract   PDF   HTML
E. Baxter, L. Gondara, C. Lohrisch, S. Chia, K. Gelmon, M. Hayes, A. Davidson, S. Tyldesley
Vol 22, No 5 (2015) Using tablet-based technology in patient education about systemic therapy options for early-stage breast cancer: a pilot study Abstract   PDF   HTML
E.R. Morgan, K. Laing, J. McCarthy, F. McCrate, M.D. Seal
Vol 22, No 2 (2015) Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada Abstract   PDF   HTML
A.J. Coldman, N. Phillips, J. Brisson, W. Flanagan, M. Wolfson, C. Nadeau, N. Fitzgerald, A.B. Miller
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada Abstract   PDF   HTML
C. Popadiuk, C.L. Gauvreau, M. Bhavsar, C. Nadeau, K. Asakawa, W.M. Flanagam, M.C. Wolfson, A.J. Coldman, S. Memon, N. Fitzgerald, J. Lacombe, A.B. Miller
Vol 26, No 4 (2019) Utility of a chemotherapy toxicity prediction tool for older patients in a community setting Abstract   PDF   HTML
C. Mariano, R. Jamal, P. Bains, S. Hejazi, L. Chao, J. Wan, J. Ho
Vol 22, No 5 (2015) Utilization of magnetic resonance imaging in breast cancer screening Abstract   PDF   HTML
D. Lin, L. Moy, D. Axelrod, J. Smith
Vol 21, No 3 (2014) Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease Abstract   PDF   HTML
J.A. Broomfield, J.N. Greenspoon, A. Swaminath
Vol 15, No 5 (2008) Validation of Symptom Clusters in Patients with Metastatic Bone Pain Abstract   PDF
Stephanie Hadi, Liying Zhang, Amanda Hird, Eric de Sa, Edward Chow
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada Abstract   PDF   HTML
J. Lemieux, S. Audet
Vol 25, No 2 (2018) Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario Abstract   PDF   HTML
K.E. Brennan, S.F. Hall, T.E. Owen, R.J. Griffiths, Y. Peng
Vol 21, No 4 (2014) Venous thromboembolism in cancer patients: a call for more awareness Abstract   PDF   HTML
A. Delluc, M. Carrier
Vol 23, No 4 (2016) Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia Abstract   PDF   HTML
H. Sibai, J.T. Seki, T.Q. Wang, N. Sakurai, E.G. Atenafu, K.W.L. Yee, A.C. Schuh, V. Gupta, M.D. Minden, A.D. Schimmer, J.M. Brandwein
Vol 17, No 2 (2010) Vera Peters and the conservative management of early-stage breast cancer Abstract   PDF
D. H. Cowan
Vol 15, No 5 (2008) Vera Peters and the curability of Hodgkin's disease. Abstract   PDF
Donald Henry Cowan
Vol 19, No 6 (2012) Views of breast and colorectal cancer survivors on their routine follow-up care Abstract   PDF   HTML
R. Urquhart, A. Folkes, J. Babineau, E. Grunfeld
Vol 22, No 4 (2015) Views of family physicians about survivorship care plans to provide breast cancer follow-up care: exploration of results from a randomized controlled trial Abstract   PDF   HTML
M.A. O'Brien, E. Grunfeld, J. Sussman, G. Porter, M. Hammond Mobilio
2008: Presentations from the Integrating Wellness into Cancer Care Conference Visions on Wellness from a Single Large Academic Institution to a Provincial Plan Abstract   PPT Presentation
Bob Bell, Terry Sullivan
Vol 24, No 6 (2017) Wait times for diagnosis and treatment of lung cancer: a single-centre experience Abstract   PDF   HTML
C. Labbé, M. Anderson, S. Simard, L. Tremblay, F. Laberge, R. Vaillancourt, Y. Lacasse
Vol 22, No 5 (2015) Wait times for prostate cancer treatment and patient perceptions of care in Canada: a mixed-methods report Abstract   PDF   HTML
K. Tran, C. Sandoval, R. Rahal, G. Porter, R. Siemens, J. Hernandez, S. Fung, C. Louzado, J Liu, H. Bryant
Vol 20, No 6 (2013) Weakly hormone receptor– positive breast cancer and use of adjuvant hormonal therapy Abstract   PDF   HTML
C.M. Lin, J. Jaswal, T. Vandenberg, A. Tuck, M. Brackstone
Vol 17, No 4 (2010) Weathering storms: a cohort study of how participation in a mindfulness based stress reduction program benefits women after breast cancer treatment Abstract   PDF
R.H. Matousek, P.L. Dobkin
Vol 18, No 1 (2011) Weekly paclitaxel in ovarian cancer—the latest success story Details   PDF   HTML
A. Jain, B. Dubashi, K.S Reddy, P. Jain
Vol 22, No 6 (2015) Wellness Beyond Cancer Program: Building an effective survivorship program Abstract   PDF   HTML
M. Rushton, R. Morash, G. Larocque, C. Liska, S. Stoica, C. Degrasse, R. Segal
2008: Presentations from the Integrating Wellness into Cancer Care Conference Wellspring: An Important Part of Integrative Health Care Abstract   PPT Presentation
Presenter Morrison
Vol 17, No 6 (2010) What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? Abstract   PDF
E. Yu, P. Tai, R. Malthaner, L. Stitt, G. Rodrigues, R. Dar, B. Yaremko, J. Younus, M. Sanatani, M. Vincent, B. Dingle, D. Fortin, R. Inculet
Vol 25, No 4 (2018) What characterizes cancer family history collection tools? A critical literature review Abstract   PDF   HTML
J.E. Cleophat, H. Nabi, S. Pelletier, K. Bouchard, M. Dorval
Vol 25, No 3 (2018) What do primary care providers think about implementing breast cancer survivorship care? Abstract   PDF   HTML
M. Luctkar-Flude, A. Aiken, M.A. McColl, J. Tranmer
Vol 26, No 2 (2019) What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer? Abstract   PDF   HTML
Y. J. Ko, M. Abdelsalam, P. Kavan, H. Lim, P. A. Tang, M. Vincent, R. Wong, M. Kish, S. Gill
Vol 20, No 2 (2013) What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer? Abstract   PDF   HTML
C. Cox, C.M. Holloway, A. Shaheta, S. Nofech-Mozes, F.C. Wright
Vol 19, No 2 (2012) What is the optimal management of dysphagia in metastatic esophageal cancer? Abstract   PDF   HTML
W.C. Hanna, M. Sudarshan, D. Roberge, M. David, K.A. Waschke, S. Mayrand, T. Alcindor, L.E. Ferri
Vol 19, No 6 (2012) What is the optimal management of dysphagia in metastatic esophageal cancer? Details   PDF   HTML
F. Cavallin, M. Scarpa, M. Cagol, R. Alfieri, C. Castoro
2008: Presentations from the Integrating Wellness into Cancer Care Conference What the Patient wants from the Healthcare Professional Abstract   PPT Presentation
Charlotte Schultz
Vol 24, No 5 (2017) What we learned in kindergarten: five tips for collaboration in oncology Abstract   PDF   HTML
A. Arnaout, A.A. Joy, M. Juliao, M. Clemons
Vol 24, No 3 (2017) When cancer hits the streets Abstract   PDF   HTML
K.I. Stajduhar, A. Mollison, D. Gleave, S.W. Hwang
Vol 23, No 5 (2016) When Impatience is a Virtue Abstract   PDF   HTML
N. Mills
Vol 20, No 1 (2013) When jurisdictional boundaries become barriers to good patient care Abstract   PDF   HTML
J. Stephen, K. Fergus, S. Sellick, M. Speca, J. Taylor-Brown, J. Turner, K. Collie, D. McLeod, A. Rojubally
Vol 26, No 3 (2019) When the oncologist becomes the patient Abstract   PDF   HTML
E. Aitini
Vol 24, No 4 (2017) When the patient is also a carer Abstract   PDF   HTML
E. Warner
Vol 20, No 1 (2013) When the tumour is not the culprit: avascular necrosis of the hip in a patient with castration-resistant prostate cancer Abstract   PDF   HTML
E. Chan, G. Chan, L. Ehrlich, P. Hull, H. Kreder, W. Chu, E. Chow, U. Emmenegger
Vol 24, No 4 (2017) Wherein the authors attempt to minimize the confusion generated by their study “Breast cancer mortality after a diagnosis of ductal carcinoma in situ” by several commentators who disagree with them and a few who don’t: a qualitative study Abstract   PDF   HTML
S.A. Narod, H. Ahmed, V. Sopik
Vol 22, No 5 (2015) White Abstract   PDF   HTML
S.B. Weiner
Vol 26, No 3 (2019) Whither palliative care? Abstract   PDF   HTML
C. L. Watt, J. Downar
Vol 26, No 4 (2019) Who cares? The impact on caregivers of suspected mining-related lung cancer Abstract   PDF   HTML
N. Lightfoot, L. MacEwan, L. Tufford, D. L. Holness, C. Mayer, D. M. Kramer
Vol 26, No 2 (2019) Why are we organizing another costing supplement in Current Oncology? Abstract   PDF   HTML
N. Mittmann
1601 - 1700 of 1709 Items << < 12 13 14 15 16 17 18 > >>